Movantik and Dyskinesia - a phase IV clinical study of FDA data

Summary:

Dyskinesia is reported as a side effect among people who take Movantik (naloxegol oxalate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin C, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Dyskinesia when taking Movantik. It is created by eHealthMe based on reports of 3,501 people who have side effects when taking Movantik from the FDA, and is updated regularly.

What is Movantik?

Movantik has active ingredients of naloxegol oxalate. It is often used in constipation. eHealthMe is studying from 3,523 Movantik users. Check the latest studies of Movantik.

What is Dyskinesia?

Dyskinesia (abnormality or impairment of voluntary movement) is found to be associated with 1,519 drugs and 1,733 conditions by eHealthMe. Check the latest studies of Dyskinesia.

On Jul, 19, 2026

3,501 people reported to have side effects when taking Movantik.
Among them, 14 people (0.4%) have Dyskinesia.

Among these 14 people:

How long have people been on Movantik when they have Dyskinesia? *

What is the gender of people who have Dyskinesia when taking Movantik? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Dyskinesia when taking Movantik? *

What are other drugs people take besides Movantik? *

Vitamin C: 6 people, 42.86%
Miralax: 5 people, 35.71%
Rocephin: 4 people, 28.57%
Linzess: 4 people, 28.57%
Vesicare: 4 people, 28.57%
Zofran: 3 people, 21.43%
Hydroxyzine Pamoate: 3 people, 21.43%
Fluticasone Propionate: 3 people, 21.43%
Furosemide: 3 people, 21.43%
Gabapentin: 3 people, 21.43%

What are other side effects people have besides Dyskinesia? *

Fainting (loss of consciousness and postural tone): 4 people, 28.57%
Fall: 4 people, 28.57%
Tremor (trembling or shaking movements in one or more parts of your body): 4 people, 28.57%
Therapeutic Response Unexpected: 4 people, 28.57%
Joint Pain: 3 people, 21.43%
Infusion Site Discomfort: 3 people, 21.43%
Memory Loss: 3 people, 21.43%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 21.43%
Loss Of Consciousness: 3 people, 21.43%
Ligament Sprain (ligament stretched): 3 people, 21.43%

What are the existing conditions these people have? *

Parkinson's Disease: 4 people, 28.57%
Prostatic Disorder: 3 people, 21.43%
Neuropathy Peripheral (surface nerve damage): 3 people, 21.43%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 21.43%
Immunodeficiency Common Variable: 3 people, 21.43%
Hypergammaglobulinaemia (elevated levels of gamma globulin): 3 people, 21.43%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 21.43%
Stress And Anxiety: 1 person, 7.14%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 7.14%
Pain: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Movantik and have Dyskinesia?

- Check whether Dyskinesia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Movantik:

Movantik (3,523 reports)

Dyskinesia treatments and more:

Dyskinesia (50,549 reports)

Browse all side effects of Movantik:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyskinesia:

Dyskinesia (1,519 drugs)

Browse all the conditions that are associated with Dyskinesia:

Dyskinesia (1,733 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on naloxegol oxalate (the active ingredients of Movantik) and Movantik (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.